• Thermo Fisher buys Brammer Bio for $1.7bn pharmatimes
    March 27, 2019
    Thermo Fisher, another life sciences group pitching in on the future of gene therapy, has announced plans to enter into a definitive agreement to acquire Brammer Bio for approximately $1.7 billion.
  • Brammer Bio, Sarepta Enter Long-term Mfg. Tie-up contractpharma
    June 19, 2018
  • Brammer Bio expands Cell and Gene Therapy Capacity in Florida and Massachusetts biospectrumasia
    September 27, 2017
PharmaSources Customer Service